Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.

JCI Insight · 2018 · PMC6237460 · PMID 30282824

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Importantly, Ki-67 positivity in total and IgG4 + CD8 T cells gradually decreased from day 28 after the final dose, and did not exhibit an increasing trend even after reinitiation of treatment ( Figure 7C ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.